BR0001144A - Composicão em forma de gel, creme, ou creme gelde diclofenaco de sódio ou potassio à base devitamina-e, papaìna e hialuronidase - Google Patents

Composicão em forma de gel, creme, ou creme gelde diclofenaco de sódio ou potassio à base devitamina-e, papaìna e hialuronidase

Info

Publication number
BR0001144A
BR0001144A BR0001144-4A BR0001144A BR0001144A BR 0001144 A BR0001144 A BR 0001144A BR 0001144 A BR0001144 A BR 0001144A BR 0001144 A BR0001144 A BR 0001144A
Authority
BR
Brazil
Prior art keywords
cream
gel
hyaluronidase
composition
papain
Prior art date
Application number
BR0001144-4A
Other languages
English (en)
Other versions
BR0001144B1 (pt
Inventor
Cristiano Alberto Ribeiro Santana
Gilberto De Nucci
Marcio Falci
Original Assignee
Cristiano Alberto Ribeiro Santana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cristiano Alberto Ribeiro Santana filed Critical Cristiano Alberto Ribeiro Santana
Priority to BRPI0001144-4B1A priority Critical patent/BR0001144B1/pt
Priority to US10/204,464 priority patent/US20030103955A1/en
Priority to MXPA02008116A priority patent/MXPA02008116A/es
Priority to CA2399219A priority patent/CA2399219C/en
Priority to PCT/BR2001/000019 priority patent/WO2001060399A1/en
Priority to DE60112578T priority patent/DE60112578T2/de
Priority to EP01913407A priority patent/EP1299114B1/en
Priority to ES01913407T priority patent/ES2244591T3/es
Priority to AU39037/01A priority patent/AU3903701A/en
Priority to AT01913407T priority patent/ATE301469T1/de
Priority to PT01913407T priority patent/PT1299114E/pt
Publication of BR0001144A publication Critical patent/BR0001144A/pt
Publication of BR0001144B1 publication Critical patent/BR0001144B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO EM FORMA DE GEL, CREME OU CREME GELDE DICLOFENACO DE SóDIO OU POTáSSIO à BASE DEVITAMINA-E, PAPAìNA E HIALURONIDASE".A presente invenção refere-se à uma nova composição em formade gel, creme ou creme gel de diclofenaco de sódio ou potássio à1% à base devitamina-e, papaína e hialuronidase, com composição química:base anidro:POLIETILENO GLICOL 0,25g, BUTIL PARABENO 0,01g, PROPILENO GLICOL, 0,20g óLEO MINERAL DESODORIZADO, 0,16g EDITA SÊDICO TETRA, 0,002g TWEEN80, 0,40gPAPAìNA - 6000 USP/MG, 0,002g HIALURONIDASE, 220 utr/mgVITAMINA E OLEOSA, 0,020g DICLOFENACO DE SóDIO OU POTáSSIO à 1%
BRPI0001144-4B1A 2000-02-21 2000-02-21 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase BR0001144B1 (pt)

Priority Applications (11)

Application Number Priority Date Filing Date Title
BRPI0001144-4B1A BR0001144B1 (pt) 2000-02-21 2000-02-21 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
US10/204,464 US20030103955A1 (en) 2000-02-21 2001-02-20 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
MXPA02008116A MXPA02008116A (es) 2000-02-21 2001-02-20 Composicion farmaceutica de diclofenaco a base de vitamina e, papaina e hialuronidasa.
CA2399219A CA2399219C (en) 2000-02-21 2001-02-20 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
PCT/BR2001/000019 WO2001060399A1 (en) 2000-02-21 2001-02-20 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
DE60112578T DE60112578T2 (de) 2000-02-21 2001-02-20 Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
EP01913407A EP1299114B1 (en) 2000-02-21 2001-02-20 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
ES01913407T ES2244591T3 (es) 2000-02-21 2001-02-20 Composicion farmaceutica de diclofenac basada en vitamina e, papaina y hialuronidasa.
AU39037/01A AU3903701A (en) 2000-02-21 2001-02-20 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
AT01913407T ATE301469T1 (de) 2000-02-21 2001-02-20 Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
PT01913407T PT1299114E (pt) 2000-02-21 2001-02-20 Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0001144-4B1A BR0001144B1 (pt) 2000-02-21 2000-02-21 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase

Publications (2)

Publication Number Publication Date
BR0001144A true BR0001144A (pt) 2001-11-27
BR0001144B1 BR0001144B1 (pt) 2013-10-22

Family

ID=3943888

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0001144-4B1A BR0001144B1 (pt) 2000-02-21 2000-02-21 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase

Country Status (11)

Country Link
US (1) US20030103955A1 (pt)
EP (1) EP1299114B1 (pt)
AT (1) ATE301469T1 (pt)
AU (1) AU3903701A (pt)
BR (1) BR0001144B1 (pt)
CA (1) CA2399219C (pt)
DE (1) DE60112578T2 (pt)
ES (1) ES2244591T3 (pt)
MX (1) MXPA02008116A (pt)
PT (1) PT1299114E (pt)
WO (1) WO2001060399A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0000426B1 (pt) * 2000-01-28 2014-09-30 Biolab Sanus Farmaceutica Ltda Composição farmacêutica
BR0006719A (pt) * 2000-05-04 2001-09-25 Cristiano Alberto Ribeiro Sant Composição em forma de creme, gel e creme gel aplicada na terapêutica da doença de peyronie, de colagenoses e patologias fibróticas à base de vitamina-e, papaìna 2% e hialuronidase
WO2003018063A1 (en) * 2001-08-27 2003-03-06 Medtopic Empreendimentos E Particapações S/C Ltda. Composition of a carrier substance for products based on papain and hyaluronidase
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448903A1 (fr) * 1979-02-19 1980-09-12 Martin Henri Medicament nouveau a base d'agents antimicrobiens, d'enzymes, d'anti-inflammatoires, d'anesthesique local, d'agents keratolytiques, d'agents mucolytiques et d'au moins un emulsionnant
US4855142A (en) * 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
US5296222A (en) * 1989-02-23 1994-03-22 University Of Utah Percutaneous drug delivery system
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
JP3765579B2 (ja) * 1990-08-24 2006-04-12 イーデーエーアー アーゲー 作用物質投与用超微小滴状調剤
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
DK42093D0 (da) * 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
DE4313402A1 (de) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
US5795916A (en) * 1994-08-09 1998-08-18 Tsumura & Co. Composition of external preparation

Also Published As

Publication number Publication date
ATE301469T1 (de) 2005-08-15
BR0001144B1 (pt) 2013-10-22
PT1299114E (pt) 2005-11-30
US20030103955A1 (en) 2003-06-05
DE60112578T2 (de) 2006-05-24
AU3903701A (en) 2001-08-27
DE60112578D1 (de) 2005-09-15
EP1299114B1 (en) 2005-08-10
CA2399219A1 (en) 2001-08-23
MXPA02008116A (es) 2004-06-29
EP1299114A1 (en) 2003-04-09
ES2244591T3 (es) 2005-12-16
CA2399219C (en) 2013-04-09
WO2001060399A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
BR9807383A (pt) Formulação farmacêutica que compreende amoxicilina e clavulanato
BRPI0407723B8 (pt) artigo absorvente
BR9810520A (pt) Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial
BRPI0407352A (pt) Composição para o cuidado oral, e, métodos para efetuar a estabilidade aumentada em uma composição oral contendo enzimas, e para a preparação de uma composição para o cuidado oral aquosa
BR9801652A (pt) Resorcinil-triazinas
BR9916879A (pt) Composição e método para tratamento do câncer utilizando óleos essenciais vegetais naturais
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BR9712491A (pt) Composições cosméticas
AR049829A1 (es) Procedimiento y composiciones utiles para prevenir y/o tratar las pieles sensibles y/o secas
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
AU3287200A (en) Composition comprising isoquercetin and ascorbic acid in a sustained release form
IL172773A0 (en) Formulations for the treatment of arhritis conditions
BR9914156A (pt) Formulação de 2-metil-tieno-benzodiazepina
BR0012696A (pt) Composição oftálmica
IL136101A (en) Pharmaceutical compositions containing azelaic acid
BR0213449A (pt) Comprimido mastigável contendo lisina
BR0001144A (pt) Composicão em forma de gel, creme, ou creme gelde diclofenaco de sódio ou potassio à base devitamina-e, papaìna e hialuronidase
BR0210543A (pt) Tablete macio de caldo de carne
BRPI0413535A (pt) agente tópico essencialmente anidro com atividade oral compreendendo uma ou mais substáncias sensìveis à oxidação
BR9812160A (pt) Derivados de benzoxazina e benzotiazina e seu emprego em medicamentos
CA2322967A1 (en) Prophylactic, therapeutic agent for osteoporosis
BR0210063A (pt) Composição estável e uso da mesma
WO2001022917A3 (en) Effervescent compositions comprising nimesulide
BR0309768A (pt) Composições lubrificantes anidras de aquecimento e não-irritantes
MD457G2 (ro) Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BIOLAB SANUS FARMACEUTICA LTDA. (BR/SP)

Free format text: TRANSFERIDO DE: CRISTIANO ALBERTO RIBEIRO SANTANA

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 38/51, A61K 38/48, A61K 31/196, A61K 31/355, A61K 9/00, A61P 29/00

Ipc: A61K 31/136 (2009.01), A61P 29/00 (2009.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/10/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: REFERENTE AO DESPACHO 21.6 PUBLICADO NA RPI 2554 DE 2019-12-17